宫颈癌筛查研究生课件.ppt

Thanks！ LSIL in Special Populations Women Aged 21-24 Years For women with LSIL who are aged 21-24 years, follow-up with cytology at 12-month intervals is recommended Colposcopy is not recommended For women with ASC-H or HSIL+ at the 12-month follow up, colposcopy is recommended For women with ASC-US or worse at the 24-month follow up, colposcopy is recommended For women with two consecutive negative results, return to routine screening is recommended LSIL in Special Populations Postmenopausal Women： Acceptable options for the management of postmenopausal women with LSIL and no HPV test include obtaining HPV testing, repeat cytologic testing at 6 months and 12 months, and colposcopy If the HPV test is negative or if CIN is not identified at colposcopy, repeat cytology in 12 months is recommended. If either the HPV test is positive or repeat cytology is ASC-US or greater, colposcopy is recommended If two consecutive repeat cytology tests are negative, return to routine screening is recommended LSIL in Special Populations Pregnant Women For pregnant women with LSIL, colposcopy is preferred Endocervical curettage in pregnant women is unacceptable For pregnant women aged 21-24 years, follow-up according to the guidelines for management of LSIL in women aged 21-24 years is recommended Deferring colposcopy until 6 weeks postpartum is acceptable For pregnant women who have no cytologic, histologic, or colposcopically suspected CIN2+ at the initial colposcopy, postpartum follow-up is recommended Additional colposcopic and cytologic examinations during pregnancy are unacceptable for these women LSIL in Special Populations ASC-H in Special Populations Women Aged 21-24 Years Colposcopy is recommended Further management should follow guidelines for women aged 21-24 years with HSIL. HSIL High-Grade Squamous Intraepithelial Lesion CIN 2+ is found at colposcopy in some 60% of women with HSIL Five-year cervical cancer risk is 8% among wom